GAINS for Dementia: Characterising a New Neuroimmune Pathway for Alzheimer’s Treatment
University of Exeter · United Kingdom
ARUK-funded PhD at Exeter studying GAINS, a pathway where gamma-frequency brain activity activates microglia to clear amyloid-beta. Combines mouse electrophysiology, two-photon imaging, optogenetics and pharmacology with a secondment in Edinburgh to test living human brain tissue. Suits applicants i
Neuroscience6h ago
